Clinical Trial Update: A Study to Investigate the Effect of Impaired Hepatic Function on the Pharmacokinetics of Entrectinib in Volunteers With Different Levels of Hepatic Function [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated how hepatic impairment affects the pharmacokinetics of entrectinib in volunteers with varying liver function, and results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency

Drugs mentioned

• Rozlytrek (entrectinib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatic Insufficiency | Phase 1 | Status: COMPLETED | Results posted: 2024-08-02